CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $411,605
- in 5 filings
Net −$411,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 48 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-27 | WONG RODERICK Director | Grant or award | +967,742 | $15.50 | $15.0M | 16,407,319 |
| 2018-08-27 | RTW INVESTMENTS, LP 10% owner | Other acquisition · Equity Swap (Obligation to Sell) | +1 | 1 | ||
| 2018-08-27 | RTW INVESTMENTS, LP 10% owner | Other acquisition · Equity Swap (Obligation to Buy) | +1 | 1 | ||
| 2018-08-01 | Yalamanchi Naveen Director | Sale | −637 | $22.00 | $14K | 113,641 |
| 2018-06-25 | Militello John | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2018-04-02 | SOUTHWELL DAVID P Director | Exercise or conversion | +21,875 | 38,535 | ||
| 2018-04-02 | SOUTHWELL DAVID P Director | Exercise or conversion · Restricted Stock Units | +21,875 | 65,625 | ||
| 2018-03-29 | WONG RODERICK Director | Grant or award · Stock Option (Right to Buy) | +47,000 | 47,000 | ||
| 2018-03-29 | SOUTHWELL DAVID P Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-03-29 | Yalamanchi Naveen Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-03-29 | GRANADILLO PEDRO P Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-03-29 | BOESS CARSTEN Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-03-29 | Shah Gaurav Director | Grant or award · Stock Option (Right to Buy) | +395,000 | 395,000 | ||
| 2018-03-29 | Makker Gotham Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-03-29 | Makker Gotham Director | Grant or award · Stock Option (Right to Buy) | +3,300 | $14.09 | $46K | 3,300 |
| 2018-03-29 | Patel Kinnari Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2018-03-29 | Militello John | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2018-03-29 | Schwartz Jonathan David Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 |
Page 27 of 27 · 538 trades